MYD88 and neoplasm: Recent studies revealed that EOC cells expressing TLR4 and MyD88 constitutively secrete pro-inflammatory cytokines and are resistant to the paclitaxel, and directly contributes to their own survival and tumor progression3, 4, 5, 6.